التفاصيل البيبلوغرافية
| العنوان: |
Decision Aids for Localized Prostate Cancer in Diverse Minority Men: Primary Outcome Results from a Multi-Centered Cancer Care Delivery Trial (Alliance A191402CD) |
| المؤلفون: |
Tilburt, Jon C., Zahrieh, David, Pacyna, Joel E., Petereit, Daniel G., Kaur, Judith S., Rapkin, Bruce D., Grubb, Robert L., Chang, George J., Morris, Michael J., Kovac, Evan Z., Babaian, Kara N., Sloan, Jeff A., Basch, Ethan M., Peil, Elizabeth S., Dueck, Amylou C., Novotny, Paul J., Paskett, Electra D., Buckner, Jan C., Joyce, Daniel D., Montori, Victor M., Frosch, Dominick L., Volk, Robert J., Kim, Simon P. |
| المصدر: |
Cancer |
| سنة النشر: |
2022 |
| مصطلحات موضوعية: |
Article, psy, edu |
| الوصف: |
BACKGROUND: Decision aids (DAs) can improve knowledge for prostate cancer treatment. However, the relative effects of DAs delivered within the clinical encounter and in more diverse patient populations are unknown. We performed a multi-centered cluster randomized controlled trial (RCT) with a 2×2 factorial design to test the effectiveness of within-visit as well as pre-visit DAs for localized prostate cancer, oversampling minority men. METHODS: The interventions were delivered in urology practices affiliated with the NCI Community Oncology Research Program (NCORP) Alliance Research Base. The primary outcome was prostate cancer knowledge (% correct, 12-item measure) assessed immediately after urology consultation. RESULTS: Four sites administered the pre-visit DA (n=39 patients), 4 sites administered the within-visit DA (n=44 patients), 3 sites administered both pre- and within-visit DAs (n=25 patients), and 4 sites provided usual care (n=50 patients). Median % correct in prostate cancer knowledge based on the post-visit knowledge assessment after intervention delivery were as follows—the pre+within DA study arm was 75%, the pre-visit DA only arm was 67%, within-visit DA only arm was 58%, and usual care was 58%. Neither pre-visit nor within-visit DAs had a significant impact on patient knowledge of prostate cancer and its consequences at the pre-specified 2.5% significance level (p = 0.132 and 0.977, respectively). CONCLUSIONS: Decision aids for localized prostate cancer treatment provided at two different points in the care continuum in a trial that oversampled minority men did not confer measurable gains in prostate cancer knowledge. |
| نوع الوثيقة: |
text |
| اللغة: |
English |
| العلاقة: |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882149Test/ |
| الإتاحة: |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882149Test/ |
| حقوق: |
undefined |
| رقم الانضمام: |
edsbas.E6FA9891 |
| قاعدة البيانات: |
BASE |
